Atticus Wealth Management, LLC Genmab A/S Transaction History

Atticus Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 15, 2021	SELL	$30.92 - $44.4 $33,826 - $48,573	-1,094 Closed	0 $0
Q3 2020 Oct 21, 2020	SELL	$33.07 - $38.68 $99 - $116	-3 Reduced 0.27%	1,094 $40,000
Q2 2020 Jul 15, 2020	BUY	$20.05 - $33.89 $21,994 - $37,177	1,097 New	1,097 $37,000
Q1 2020 Apr 23, 2020	SELL	$17.15 - $25.22 $154 - $226	-9 Closed	0 $0
Q4 2019 Feb 03, 2020	BUY	$18.88 - $24.14 $169 - $217	9 New	9 $0

238

48.6M

6.8K

27.6K

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $14.9B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

Get notified when there are updates to the investment portfolio of Atticus Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Atticus Wealth Management, LLC with notifications on news.